Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

OnKure
1067 South Hover Street Unit E, PMB #204
Longmont, CO 80501
Phone: 720-323-9110
http://onkuretherapeutics.com/

OnKure Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure's product candidates aim to treat cancer by targeting malignant cells and circulating lymphocytes, through alteration of the tumor microenvironment such that checkpoint inhibition is optimized, and through delaying kinase inhibitor resistance. OnKure's most advanced programs target Class-1 histone deacetylase (HDAC) enzymes as well as HDAC6.

Key Contact
Name
Tony Piscopio
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
05/02/18 $7,000,000 Series A Delian Capital
undisclosed


Featured Reading